Transcatheter left atrial appendage occlusion is an increasingly used alternative to oral
anticoagulation in selected patients with atrial fibrillation. Pre-procedural imaging is a …

Background: Percutaneous closure of the left atrial appendage (LAA) is an alternative to
chronic oral anticoagulation to reduce stroke risk in patients with nonvalvular atrial …

Abstract Background and Aims Residual leaks are not infrequent after left atrial appendage
occlusion. However, there is still uncertainty regarding their prognostic implications. The aim …

This article has been co-published with permission in EP Europace and EuroIntervention. All
rights reserved. VC 2019 the European Heart Rhythm Association and the European …

Background: Long-term data on the safety and efficacy of left atrial appendage closure
(LAAC) for stroke prevention in patients with nonvalvular atrial fibrillation remain limited …

Aims To evaluate the safety and efficacy of left atrial appendage occlusion (LAAO) with the
Amplatzer™ Amulet™ occluder. Methods and results Patients with atrial fibrillation eligible …

Objectives: This study sought to assess the incidence and clinical impact of device related
thrombus (DRT) following precautions left atrial appendage occlusion (LAAO). Background …

Background: Left atrial appendage closure is an established therapy in patients with atrial
fibrillation. Although device-related thrombosis (DRT) is relatively rare, it is potentially linked …

Background The optimal antithrombotic therapy following left atrial appendage occlusion
(LAAO) in patients with nonvalvular atrial fibrillation (AF) remains uncertain. Objectives In …

Background In patients with end stage renal disease and atrial fibrillation (AF), undergoing
chronic dialysis, direct oral agents are contraindicated and warfarin does not fully prevent …